LGD-4033 Liquid | 10mg/ml
- Batch and lot coded with publicly visible lab reports to ensure quality and transparency.
- Less than 10% variance in concentration, guaranteeing consistency.
- Formulated and packaged to prevent evaporation in storage.
- Includes graduated 1mL pipette for convenient measurement.
- Glass bottle with UV resistance to minimize degradation.
- Tamper-proof seal to ensure safety in transit.
- Additional information
- Reviews (0)
LGD-4033, also known as Ligandrol, is a SARM that has been shown to have positive effects on muscle building, body recomposition, sex drive, and bone density. Already in human trials, Ligandrol has been shown to be highly selective for muscle and bone cells, largely ignoring prostate or sebaceous cells. This makes the side effects for LGD-4033 minimal. LGD-4033 is a selective androgen receptor modulator (SARM). While it is currently being investigated as a pharmaceutical treatment for muscle wasting and weakness associated with aging, LGD-4033 has not been approved by the U.S. Food and Drug Administration (FDA) for clinical use in humans. According to a clinical trial conducted at the Boston Medical Center’s Section of Endocrinology, Ligandrol can help improve lean body mass and muscle strength. Another study conducted in January 2013 found that Ligandrol can help increase lean muscle mass, and was generally well tolerated by test subjects. Ligandrol is on the World Anti-Doping Association’s list of prohibited drugs and has been found in drug testing samples of some athletes.
In 2015, the quarterback of the Florida Gators, Will Grier, was suspended for testing positive for ligandrol, a claim that the University of Florida denies. In 2017, Joakim Noah was banned for twenty games by the NBA for testing positive for ligandrol. In 2019, Australian swimmer Shayna Jack tested positive for ligandrol. She denies knowingly taking the substance.
The Phase 2 clinical trial, initiated on 3 November 2016, consists of 120 patients recovering from hip fracture surgery. The randomized study participants will receive either a placebo or varying dose sizes of LGD-4033 over a period of 12 weeks, with improved lean body mass as the primary endpoint. Other endpoints include satisfactory results in terms of quality of life, safety, and pharmacokinetics.
10mg/ml at 30ml per bottle.
24 – 36 hours.
Products are furnished for LABORATORY RESEARCH USE ONLY. This product should only be handled by qualified, and licensed professionals. The product may not be used as a drug, agricultural or pesticide product, food additive, or household chemical – and may not be misbranded as such. All information on this website is available for educational purposes only. Bodily introduction of any kind into humans and/or animals is strictly forbidden by law.
This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption.
Solution in PEG 400/PG
Selective Androgen Receptor Modulator
Propylene Glycol, DMSO, Ethanol
Store at room temperature, tightly sealed, away from heat, light and moisture.
LGD-4033, Ligandrol, VK5211